Skip to main content

Boston Scientific Corp

BSX
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000885725

In the last 90 days, Boston Scientific Corp insiders filed 5 open-market purchases and 0 sales; 1,485 institutions reported holding it in 13F filings for Q2 2026, worth $60.4B in total; Maverick Capital is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Boston Scientific Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
5 filings
4 insiders, $9.49M in total
Open-market sells
0 filings
Insiders trading
4
Net value
+$9.49M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Boston Scientific Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Boston Scientific Corp
NameTitleLast reported holdingLast filingFilings, past year
O'Connor Padraig AndrewEVP, Global Operations7,892Sep 3, 20264
Morano Susan EDirector13,784Aug 26, 20263
Woodworth EmilySVP, Global Controller and CAO2,930IndirectAug 12, 20264
Monson JonathanEVP and CFO9,908IndirectAug 11, 20264
Habiger David CDirector17,160Aug 7, 20264
Mahoney Michael FChairman, President & CEO22,119IndirectAug 5, 20266
Ludwig Edward JDirector30,359Aug 3, 20263
Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology64,198IndirectAug 3, 20266
Pegus CherylDirector1,770May 21, 20263
Wichmann David SDirector45,382May 11, 20261
Smith Cathy RDirector–May 11, 20262
Zane Ellen MDirector27,934May 11, 20264
Mega Jessica LDirector12,035May 11, 20261
Weber Christophe PierreDirector3,786May 11, 20262
Butcher Arthur CEVP& Grp Pres, MedSurg & APAC56,887May 4, 20265
Brown Vance REVP, GC and Corp. Secretary54,244Feb 18, 20262
O'Sullivan MiriamSVP, Chief HR Officer17,302Feb 18, 20263
Fujimori YoshiakiDirector2,081Jul 30, 20250
Sununu John EDirector54,723May 9, 20250
Sorenson John BradleyEVP, Global Operations18,705May 6, 20250
Mirviss Jeffrey B.EVP&Pres, Periph Intervent25,766Feb 25, 20250
Brennan Daniel J.EVP and CFO225,808Feb 19, 20250
Carruthers WendyEVP, Human Resources29,308Dec 4, 20240
Dockendorff Charles JDirector2,901May 13, 20240
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, Afr31,422May 13, 20240
Roux David JDirector73,591May 5, 20230
Connors Nelda JDirector8,823May 5, 20230
James DonnaDirector–May 6, 20220
Scanlon MeghanSVP,Pres,Urology Pelvic Health24,461May 2, 20220
Eddy Jodi EuerleSVP, Chief Info & Digital Off.23,263Apr 4, 20220
Olson ScottSVP & Pres, CRM, Diagnostics14,518Apr 1, 20220
Meredith Ian TEVP Global Chief Med Officer28,082Mar 29, 20220
Nanavaty MaulikSVP & Pres, Neuromodulation177,258Mar 2, 20220
Pierce David AEVP Pres MedSurg0Mar 2, 20220
Mackey Edward FEVP, Operations52,944Mar 2, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 26, 2026 (view filing)6:46 PM ETAug 251 dayMorano Susan EDirectorPPurchase+2.04K$49.22+$100.4K+17.4%13.8K after
Aug 7, 2026 (view filing)4:16 PM ETAug 52 daysHabiger David CDirectorPPurchase+2.10K$47.59+$99.9K+13.9%17.2K after
Aug 5, 2026 (view filing)4:15 PM ETAug 3-42 daysHabiger David CDirectorPPurchase+1.18K$48.13+$56.9K+8.5%15.1K after2 lots
Aug 5, 2026 (view filing)4:15 PM ETAug 32 daysMahoney Michael FChairman, President & CEOPPurchase+186.2K$48.33+$9.00M+13.3%1.59M after
Aug 3, 2026 (view filing)4:29 PM ETJul 313 daysLudwig Edward JDirectorPPurchase+5.00K$45.48+$227.4K+19.7%30.4K after
May 21, 2026 (view filing)May 201 dayPegus CherylDirectorPPurchase+1.77K$56.49+$100.0KNew position1.77K after
May 21, 2026 (view filing)May 201 dayLudwig Edward JDirectorPPurchase+3.58K$56.68+$202.9K+16.4%25.4K after
May 21, 2026 (view filing)May 19-202 daysHabiger David CDirectorPPurchase+4.45K$56.43+$251.1K+47.2%13.9K after2 lots
Feb 3, 2026 (view filing)Feb 21 dayMahoney Michael FChairman, President & CEOSSale−160.9K$93.49−$15.0M−10.2%1.41M after2 lots10b5-1
Dec 2, 2025 (view filing)Dec 11 dayButcher Arthur CEVP& Grp Pres, MedSurg & APACSSale−17.3K$101.55−$1.76M−42.3%23.6K after10b5-1
Nov 6, 2025 (view filing)Nov 6Same dayZane Ellen MDirectorSSale−12.9K$98.28−$1.27M−34.8%24.1K after10b5-1
Nov 4, 2025 (view filing)Nov 31 dayFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−50.0K$99.47−$4.97M−21.9%178.3K after3 lots10b5-1
Oct 28, 2025 (view filing)Oct 27-281 dayZane Ellen MDirectorSSale−12.9K$101.38−$1.31M−34.8%24.1K after2 lots10b5-1
Oct 1, 2025 (view filing)Oct 1Same dayFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−50.0K$98.47−$4.92M−21.9%178.3K after2 lots10b5-1
Sep 3, 2025 (view filing)Sep 21 dayFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−50.0K$105.43−$5.27M−21.9%178.3K after2 lots10b5-1
Aug 4, 2025 (view filing)Aug 13 daysFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−50.0K$104.63−$5.23M−21.9%178.3K after10b5-1
Aug 4, 2025 (view filing)Aug 13 daysButcher Arthur CEVP& Grp Pres, MedSurg & APACSSale−17.3K$104.63−$1.81M−42.3%23.6K after10b5-1
Jul 30, 2025 (view filing)Jul 291 dayFujimori YoshiakiDirectorSSale−2.90K$106.99−$310.4K−58.2%2.08K after
Jul 28, 2025 (view filing)Jul 253 daysLudwig Edward JDirectorSSale−4.00K$106.03−$424.1K−17.8%18.5K after
Jul 2, 2025 (view filing)Jul 11 dayFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−50.0K$106.97−$5.35M−21.9%178.3K after10b5-1
Jun 4, 2025 (view filing)Jun 4Same dayFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−56.4K$102.88−$5.80M−24.0%178.3K after10b5-1
Jun 3, 2025 (view filing)Jun 21 dayMahoney Michael FChairman, President & CEOSSale−164.4K$103.69−$17.1M−10.0%1.48M after2 lots10b5-1
May 30, 2025 (view filing)May 291 dayLudwig Edward JDirectorSSale−4.00K$104.59−$418.4K−15.1%22.5K after
May 22, 2025 (view filing)May 211 dayBrown Vance RSVP, GC and Corp. SecretarySSale−4.83K$106.42−$513.6K−13.3%31.4K after10b5-1
May 6, 2025 (view filing)May 51 daySorenson John BradleyEVP, Global OperationsSSale−4.57K$104.54−$478.0K−19.6%18.7K after10b5-1
May 5, 2025 (view filing)May 14 daysMahoney Michael FChairman, President & CEOSSale−164.4K$102.48−$16.9M−9.7%1.54M after2 lots10b5-1
May 5, 2025 (view filing)May 14 daysButcher Arthur CEVP& Grp Pres, MedSurg & APACSSale−17.3K$102.06−$1.77M−43.8%22.2K after10b5-1
Apr 22, 2025 (view filing)Apr 211 dayBrown Vance RSVP, GC and Corp. SecretarySSale−4.83K$95.09−$458.9K−11.8%36.2K after10b5-1
Apr 2, 2025 (view filing)Apr 11 dayMahoney Michael FChairman, President & CEOSSale−164.4K$100.01−$16.4M−9.3%1.59M after10b5-1
Mar 24, 2025 (view filing)Mar 213 daysBrown Vance RSVP, GC and Corp. SecretarySSale−4.83K$100.85−$486.7K−10.5%41.0K after10b5-1
Mar 5, 2025 (view filing)Mar 3-42 daysWoodworth EmilySVP, Global Controller and CAOSSale−7.63K$104.95−$800.9K−94.6%432 after2 lots10b5-1
Mar 3, 2025 (view filing)Feb 283 daysWoodworth EmilySVP, Global Controller and CAOSSale−9.89K$101.13−$999.9K−85.8%1.63K after10b5-1
Feb 25, 2025 (view filing)Feb 24-251 dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−7.36K$104.16−$766.9K−22.2%25.8K after2 lots10b5-1
Feb 24, 2025 (view filing)Feb 24Same dayZane Ellen MDirectorSSale−13.6K$104.23−$1.42M−28.0%34.9K after10b5-1
Feb 21, 2025 (view filing)Feb 21Same dayBrown Vance RSVP, GC and Corp. SecretarySSale−4.83K$104.64−$505.0K−9.5%45.8K after10b5-1
Feb 19, 2025 (view filing)Feb 18-191 daySorenson John BradleyEVP, Global OperationsSSale−5.96K$104.84−$624.9K−22.1%21.0K after2 lots10b5-1
Feb 19, 2025 (view filing)Feb 19Same dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−1.51K$105.35−$159.1K−4.4%33.1K after10b5-1
Feb 19, 2025 (view filing)Feb 18-191 dayBrennan Daniel J.EVP and CFOSSale−84.9K$105.10−$8.92M−27.3%225.8K after3 lots10b5-1
Feb 18, 2025 (view filing)Feb 144 daysSorenson John BradleyEVP, Global OperationsSSale−1.20K$106.31−$127.7K−4.5%25.4K after10b5-1
Feb 13, 2025 (view filing)Feb 121 daySorenson John BradleyEVP, Global OperationsSSale−6.39K$105.06−$671.2K−20.8%24.3K after10b5-1
Feb 13, 2025 (view filing)Feb 121 dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−13.0K$105.06−$1.37M−31.4%28.5K after10b5-1
Feb 13, 2025 (view filing)Dec 3, 202472 daysLateFitzgerald Joseph MichaelEVP & Group Pres, CardiologyPPurchase+50$90.29+$4.51K0.0%148.2K after
Feb 13, 2025 (view filing)Dec 10, 202465 daysLateFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−20$89.97−$1.80K0.0%148.1K after
Feb 13, 2025 (view filing)Feb 121 dayBrennan Daniel J.EVP and CFOSSale−15.1K$105.07−$1.59M−5.9%241.5K after10b5-1
Feb 12, 2025 (view filing)Feb 111 dayLudwig Edward JDirectorSSale−12.0K$105.48−$1.27M−33.0%24.4K after
Feb 10, 2025 (view filing)Feb 73 daysSorenson John BradleyEVP, Global OperationsSSale−6.53K$104.97−$685.2K−19.8%26.4K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayButcher Arthur CEVP& Grp Pres, MedSurg & APACSSale−17.3K$101.80−$1.76M−75.9%5.50K after2 lots10b5-1
Jan 3, 2025 (view filing)Jan 2-31 daySorenson John BradleyEVP, Global OperationsSSale−6.46K$89.96−$581.2K−16.4%33.0K after2 lots10b5-1
Jan 3, 2025 (view filing)Jan 3Same dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−7.15K$89.86−$642.7K−20.1%28.5K after10b5-1
Jan 3, 2025 (view filing)Jan 3Same dayBrennan Daniel J.EVP and CFOSSale−9.69K$89.86−$870.7K−4.1%223.9K after10b5-1